Regeneration of pancreatic islets by amniotic fluid stem cell therapy
First Claim
Patent Images
1. A method of treating diabetes in a mammalian subject in need thereof, comprising the steps of:
- (a) providing mammalian amniotic fluid stem cells, wherein said cells are optionally differentiated into pancreatic-like cells; and
then (b) administering said cells to said subject in an amount effective to treat diabetes.
1 Assignment
0 Petitions
Accused Products
Abstract
A method of treating diabetes in a mammalian subject is carried out by: (a) providing mammalian amniotic fluid stem cells, and then (b) administering the cells to the subject in an amount effective to treat diabetes. Optionally, the cells may be differentiated into pancreatic-like cells or at least treated to initiate subsequent differentiation into-pancreatic-like cells, prior to administration.
-
Citations
35 Claims
-
1. A method of treating diabetes in a mammalian subject in need thereof, comprising the steps of:
-
(a) providing mammalian amniotic fluid stem cells, wherein said cells are optionally differentiated into pancreatic-like cells; and
then(b) administering said cells to said subject in an amount effective to treat diabetes. - View Dependent Claims (2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25, 34)
-
- 26. A pharmaceutical composition useful for the treatment of diabetes comprising, pancreatic-like cells in a pharmaceutically acceptable carrier, wherein said pancreatic-like cells are differentiated from amniotic fluid stem cells.
Specification